The reference multimedia journal in interventional cardiology

issue

Feb 19, 2021

Volume 16 Number 14

In this edition: management of Infective endocarditis after TAVI; characterisation of embolic debris with different TAVI devices; IVUS assessment to predict or prevent coronary artery occlusion after valve-in-valve TAVI. A mini focus on antithrombotic therapy in coronary interventions: the PENDULUM registry and high bleeding risk; clopidogrel vs ticagrelor in STEMI patients from the MIRTOS study; the TALOS-AMI trial design for DAPT de-escalation. An EAPCI position statement on elective cardiovascular procedures during the COVID-19 pandemic; the DESSOLVE III OCT study; the prognostic value of thermodilution-derived coronary flow capacity in patients with stable CAD; ventricular tachycardia, revascularisation of infarct-related artery chronic occlusion and myocardial scar; and more...

In this issue of EuroIntervention

Infective endocarditis after TAVI; IVUS assessment in valve-in-valve procedures; a mini focus on antithrombotic therapy in coronary interventions; an EAPCI position statement on elective procedures during COVID-19; and more…

Capodanno D

free

Interventions for valvular disease and heart failure

A review of recommendations for infective endocarditis prevention in patients undergoing transcatheter aortic valve implantation

Conen A, Stortecky S, Moreillon P, Hannan M, Franzeck F, Jeger RV, Widmer A

10.4244/EIJ-D-19-00993

free

Heterogeneity of debris captured by cerebral embolic protection filters during TAVI

Kroon H, von der Thusen J, Ziviello F, van Wiechen M, Ooms J, Kardys I, Schipper M, van Gils L, Daemen J, de Jaegere P, Van Mieghem NM

10.4244/EIJ-D-20-00744

free

Editorial comment

Cerebral embolic protection during TAVI: the game is not over

Bagur R, Sposato L

10.4244/EIJV16I14A201

free

Intravascular ultrasound assessment of coronary ostia following valve-in-valve transcatheter aortic valve implantation

Pighi M, Lunardi M, Pesarini G, Castriota F, Venturi G, Gottin L, Scarsini R, Ferrero V, Ribichini F

10.4244/EIJ-D-20-00611

free

Intravascular ultrasound guidance for valve-in-valve transcatheter pulmonary valve replacement

Kalinczuk L, Swierczewski M, Mintz GS, Demkow M

10.4244/EIJ-D-20-00427

free

Coronary interventions - Mini Focus on Antithrombotic Therapy

High bleeding risk and clinical outcomes in East Asian patients undergoing percutaneous coronary intervention: the PENDULUM registry

Nakamura M, Kadota K, Nakao K, Nakagawa Y, Shite J, Yokoi H, Kozuma K, Tanabe K, Iijima R, Harada A, Kuroda T, Murakami Y

10.4244/EIJ-D-20-00345

free

Editorial comment

Consolidating the value of the standardised ARC-HBR definition

Gargiulo G, Esposito G

10.4244/EIJV16I14A202

free

Ticagrelor versus clopidogrel in patients with STEMI treated with thrombolysis: the MIRTOS trial

Hamilos M, Kanakakis J, Anastasiou I, Karvounis C, Vasilikos V, Goudevenos J, Michalis L, Koutouzis M, Tsiafoutis I, Raisakis K, Stakos D, Hahalis G, Vardas P

10.4244/EIJ-D-20-00268

free

Editorial comment

Thrombolysis in ST-elevation myocardial infarction is not dead

Kala P

10.4244/EIJV16I14A203

free

A prospective, multicentre, randomised, open-label trial to compare the efficacy and safety of clopidogrel versus ticagrelor in stabilised patients with acute myocardial infarction after percutaneous coronary intervention: rationale and design of the TALOS-AMI trial

Park M, Kim C, Kim MC, Choo E, Hwang B, Park C, Kim H, Yoo K, Jeon D, Jeong MH, Seung K, Ahn Y, Chang K

10.4244/EIJ-D-20-00187

free

Coronary interventions

Performing elective cardiac invasive procedures during the COVID-19 outbreak: a position statement from the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

Chieffo A, Tarantini G, Naber CK, Barbato E, Roffi M, Stefanini G, Buchanan G, Buszman P, Moreno R, Zawiślak B, Cayla G, Danenberg H, Da Silveira J, Nef H, James S, Mauri Ferre J, Voskuil M, Witt N, Windecker S, Baumbach A, Dudek D

10.4244/EIJ-D-20-01291

free

Neointimal hyperplasia of ultra-thin stents with microcrystalline sirolimus or durable polymer everolimus-eluting stents: 6- and 24-month results of the DESSOLVE III OCT study

Milewski K, Takahashi K, Asano T, Katagiri Y, Hochul M, Buszman P, Tomaniak M, Gorycki B, Zurakowski A, Janas A, Mlodziankowski A, Kachel M, Wykrzykowska JJ, Wijns W, de Winter R, Buszman P, Onuma Y, Serruys PW

10.4244/EIJ-D-18-01201

free

Prognostic significance of thermodilution-derived coronary flow capacity in patients with deferred revascularisation

Hoshino M, Kanaji Y, Hamaya R, Kanno Y, Hada M, Yamaguchi M, Sumino Y, Usui E, Murai T, Lee T, Yonetsu T, Kakuta T

10.4244/EIJ-D-19-00029

free

Editorial comment

Ischaemic risk stratification after deferral of revascularisation on the basis of fractional flow reserve

Echavarria-Pinto M, van de Hoef TP

10.4244/EIJV16I14A204

free

Impact of chronic total coronary occlusion revascularisation on infarct-related myocardial scars responsible for recurrent ventricular tachycardia

Myat A, Patel M, Silberbauer J, Hildick-Smith D

10.4244/EIJ-D-18-01117

free